{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:42:39Z","timestamp":1788925359518,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.toxlet.2023.10.014","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T21:57:09Z","timestamp":1698357429000},"page":"15-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Differentiated and non-differentiated HepaRG\u2122 cells: A possible in-vitro model system for early hepatocarcinogenesis and non-genotoxic carcinogens"],"prefix":"10.1016","volume":"390","author":[{"given":"Michael","family":"Gutmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Stimpfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Langmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Koudelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Mir-Karner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Grasl-Kraupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2023.10.014_bib1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.tiv.2012.05.008","article-title":"Optimization of the HepaRG cell model for drug metabolism and toxicity studies","volume":"26","author":"Anth\u00e9rieu","year":"2012","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.toxlet.2023.10.014_bib2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2013.04.025","article-title":"Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis","volume":"59","author":"B\u00f6hm","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib3","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/10408444.2018.1458818","article-title":"Is current risk assessment of non-genotoxic carcinogens protective?","volume":"48","author":"Braakhuis","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib4","article-title":"Cyproterone acetate acts as a disruptor of the aryl hydrocarbon receptor","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxlet.2023.10.014_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408444.2013.835784","article-title":"Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPAR\u03b1) as a case study","volume":"44","author":"Corton","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib6","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.ajpath.2018.07.016","article-title":"Heparin-binding epidermal growth factor\u2013like growth factor as a critical mediator of tissue repair and regeneration","volume":"188","author":"Dao","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib7","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1873-3468.13489","article-title":"Functional characterization and mechanistic modeling of the human cytochrome P450 enzyme CYP4A22","volume":"593","author":"Durairaj","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxlet.2023.10.014_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E","article-title":"Primary carcinoma of the liver: a study of 100 cases among 48 900 necropsies","volume":"7","author":"Edmondson","year":"1954","journal-title":"Cancer"},{"key":"10.1016\/j.toxlet.2023.10.014_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073938","article-title":"A Toxicogenomic approach for the prediction of murine hepatocarcinogenesis using Ensemble Feature Selection","volume":"8","author":"Eichner","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.toxlet.2023.10.014_bib10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mrfmmm.2007.06.010","article-title":"Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies","volume":"637","author":"Ellinger-Ziegelbauer","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.toxlet.2023.10.014_bib12","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/hep.1840210506","article-title":"Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture","volume":"21","author":"G\u00f3mez-Lech\u00f3n","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2023.10.014_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tox.2007.09.030","article-title":"PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators","volume":"246","author":"Gonzalez","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2023.10.014_bib14","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/carcin\/21.7.1411","article-title":"Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis)","volume":"21","author":"Grasl-Kraupp","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.toxlet.2023.10.014_bib15","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.toxlet.2023.10.014_bib16","first-page":"396","article-title":"Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)\/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes.","author":"Haines","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.toxlet.2023.10.014_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00204-020-02939-4","article-title":"Cross-species analysis of hepatic cytochrome P450 and transport protein expression","volume":"95","author":"Hammer","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib18","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00204-020-02733-2","article-title":"Mode of action-based risk assessment of genotoxic carcinogens","volume":"94","author":"Hartwig","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mrrev.2009.07.002","article-title":"Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach","volume":"682","author":"Hernandez","year":"2009","journal-title":"Mutat. Res."},{"key":"10.1016\/j.toxlet.2023.10.014_bib20","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00204-020-02784-5","article-title":"Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens","volume":"94","author":"Jacobs","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0773.2001.880501.x","article-title":"Cyproterone acetate: a genotoxic carcinogen?","volume":"88","author":"Kasper","year":"2001","journal-title":"Pharm. Toxicol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/gast.2003.50097","article-title":"Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy","volume":"124","author":"Kiso","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2023.10.014_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2017.05.029","article-title":"Activation of the aryl hydrocarbon receptor decreases rifampicin-induced CYP3A4 expression in primary human hepatocytes and HepaRG","volume":"277","author":"Kr\u00f8yer Rasmussen","year":"2017","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.toxlet.2023.10.014_bib24","article-title":"PPAR\u03b1: an emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases","volume":"16","author":"Lin","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.toxlet.2023.10.014_bib25","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. \/Dis. Prim."},{"key":"10.1016\/j.toxlet.2023.10.014_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/carcin\/21.1.79","article-title":"Initiated rat hepatocytes in primary culture: a novel tool to study alterations in growth control during the first stage of carcinogenesis","volume":"21","author":"L\u00f6w-Baselli","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.toxlet.2023.10.014_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/toxsci\/kfu038","article-title":"Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors","volume":"139","author":"Luisier","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.toxlet.2023.10.014_bib28","first-page":"261","article-title":"The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies","volume":"115","author":"Marion","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib29","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/dmd.122.000859","article-title":"Phenobarbital in nuclear receptor activation: An update 2023","volume":"51","author":"Men","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2023.10.014_bib30","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/gb-2008-9-1-r19","article-title":"Translational control plays a prominent role in the hepatocytic differentiation of HepaRG liver progenitor cells","volume":"9","author":"Parent","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib31","unstructured":"Parzefall, W., Erber, E., Sedivy, R., Schulte-Hermann, R., 1991. Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res. 51, 1143\u20131147.PMID: 1705168."},{"key":"10.1016\/j.toxlet.2023.10.014_bib32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0887-2333(95)00107-7","article-title":"Effects of insulin, glucagon and triiodothyronine on DNA synthesis in rat hepatocyte primary cultures induced by liver tumour promoters and EGF","volume":"10","author":"Parzefall","year":"1996","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.toxlet.2023.10.014_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21671","article-title":"Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liver","volume":"46","author":"Patel","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2023.10.014_bib34","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1111\/liv.14505","article-title":"Interaction of FGF9 with FGFR3-IIIb\/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma","volume":"40","author":"Paur","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.toxlet.2023.10.014_bib35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.toxrep.2019.09.010","article-title":"MicroMatrices cross-species comparison of CAR-mediated procarcinogenic key events in a 3D liver microtissue model","volume":"6","author":"Plummer","year":"2019","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.toxlet.2023.10.014_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/13543776.2017.1272578","article-title":"Therapeutic applications of the versatile fatty acid mimetic WY14643","volume":"27","author":"Pollinger","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.toxlet.2023.10.014_bib37","first-page":"1521","article-title":"Proinflammatory mesenchymal effects of the non-genotoxic hepatocarcinogen phenobarbital: a novel mechanism of antiapoptosis and tumor promotion","volume":"36","author":"Riegler","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.toxlet.2023.10.014_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjc.6604440","article-title":"New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis","volume":"99","author":"Sagmeister","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.toxlet.2023.10.014_bib39","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1124\/mol.54.6.1113","article-title":"Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element","volume":"54","author":"Schuetz","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib40","first-page":"2556","article-title":"Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin","volume":"41","author":"Schulte-Hermann","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/j.toxlet.2023.10.014_bib41","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on patient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2023.10.014_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0306-3623(96)00246-7","article-title":"The cytochrome P450 4 (CYP4) family","volume":"28","author":"Simpson","year":"1997","journal-title":"Gen. Pharmac."},{"key":"10.1016\/j.toxlet.2023.10.014_bib43","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0192623314544378","article-title":"Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-\u03b1","volume":"43","author":"Tateno","year":"2015","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109104","article-title":"Phenobarbital in status epilepticus - rediscovery of an effective drug","volume":"141","author":"Trinka","year":"2023","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.toxlet.2023.10.014_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1006\/bbrc.1998.8703","article-title":"Plasma heparin-binding EGF-like growth factor levels in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay","volume":"29","author":"Yamada","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.toxlet.2023.10.014_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1293\/tox.2021-0027","article-title":"Application of humanized mice to toxicology studies: Evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)","volume":"34","author":"Yamada","year":"2021","journal-title":"J. Toxicol. Pathol."},{"key":"10.1016\/j.toxlet.2023.10.014_bib47","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1124\/dmd.121.000481","article-title":"Distinct roles of the sister nuclear receptors PXR and CAR in liver cancer development","volume":"50","author":"Yoshinari","year":"2022","journal-title":"Drug Metab. Dispos."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427423010779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427423010779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T05:30:02Z","timestamp":1759901402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427423010779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":47,"alternative-id":["S0378427423010779"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2023.10.014","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differentiated and non-differentiated HepaRG\u2122 cells: A possible in-vitro model system for early hepatocarcinogenesis and non-genotoxic carcinogens","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2023.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}